TickerLeague

Stock-Based Compensation for Gilead Sciences (GILD)

Stock-Based Compensation for Gilead Sciences (GILD): headline value $664.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$664.00M

YoY change

-100.0%

5Y CAGR

-100.0%

Peak year (2018)

$845.00M

Latest annual

$0

Stock-Based Compensation history chart for Gilead Sciences (GILD) from 1990 to 2025

Stock-Based Compensation history table for Gilead Sciences (GILD) from 1990 to 2025

Fiscal yearPeriod endedReportedStock-Based CompensationYoY
2025$0-100.0%
2024$835.00M+9.0%
2023$766.00M+18.9%
2022$644.00M+1.4%
2021$635.00M-1.2%
2020$643.00M+1.1%
2019$636.00M-24.7%
2018$845.00M+32.4%
2017$638.00M+67.9%
2016$380.00M-0.5%
2015$382.00M+6.1%
2014$360.00M+42.9%
2013$252.00M+20.6%
2012$209.00M+8.6%
2011$192.38M-3.8%
2010$200.04M+10.7%
2009$180.68M+17.8%
2008$153.36M
2007$0
2006$0
2005$0
2004$0
2003$0
2002$0
2001$0
2000$0
1999$0
1998$0
1997$0
1996$0
1995$0
1994$0
1992$0
1991$0
1990$0

Stock-Based Compensation values are taken from Gilead Sciences's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Gilead Sciences (GILD) stock-based compensation totalled $0 – plunged 100.0% year-over-year.

Gilead Sciences stock-based compensation has contracted on net over the period, with a -100.0% compound annual growth rate over 2020–2025 (5 years).

$845.00M stands as the all-time-high annual stock-based compensation, posted in 2018, against a low of $0 during 1990.

Gilead Sciences (GILD) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.

Gilead Sciences Stock-Based Compensation by Year

Gilead Sciences Stock-Based Compensation 2025: $0

Gilead Sciences stock-based compensation in 2025 was $0, plunged 100.0% below 2024.

Gilead Sciences Stock-Based Compensation 2024: $835.00M

Gilead Sciences stock-based compensation in 2024 was $835.00M, grew 9.0% from 2023.

Gilead Sciences Stock-Based Compensation 2023: $766.00M

Gilead Sciences stock-based compensation in 2023 was $766.00M, grew 18.9% from 2022.

Gilead Sciences Stock-Based Compensation 2022: $644.00M

Gilead Sciences stock-based compensation in 2022 was $644.00M, edged up 1.4% from 2021.

Gilead Sciences Stock-Based Compensation 2021: $635.00M

Gilead Sciences stock-based compensation in 2021 was $635.00M.

See more financial history for Gilead Sciences (GILD).

Sector peers — Stock-Based Compensation

Companies in the same sector as Gilead Sciences, ranked by their latest stock-based compensation.

CompanyStock-Based CompensationSector
Johnson & Johnson (JNJ)$1.35BHealthcare
UnitedHealth Group Incorporated (UNH)$971.00MHealthcare
AbbVie Inc. (ABBV)$955.00MHealthcare
Eli Lilly and Company (LLY)$626.00MHealthcare
AstraZeneca PLC (AZN)$0Healthcare
Merck & Co., Inc. (MRK)$0Healthcare
Amgen Inc. (AMGN)$0Healthcare
Novo Nordisk A/S (NVO)$0Healthcare

Frequently asked questions

What is Gilead Sciences's stock-based compensation?

Latest reported stock-based compensation for Gilead Sciences (GILD) is $664.00M (period ending December 31, 2025).

How has Gilead Sciences stock-based compensation changed year-over-year?

Gilead Sciences (GILD) stock-based compensation changed -100.0% year-over-year on the latest annual filing.

What is the long-term growth rate of Gilead Sciences stock-based compensation?

Gilead Sciences (GILD) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.

When did Gilead Sciences stock-based compensation hit its highest annual value?

Gilead Sciences stock-based compensation reached its highest annual value of $845.00M in 2018.

What was Gilead Sciences stock-based compensation in 2024?

Gilead Sciences (GILD) stock-based compensation in 2024 was $835.00M.

What was Gilead Sciences stock-based compensation in 2025?

Gilead Sciences (GILD) stock-based compensation in 2025 was $0.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.